Jennifer K Plichta1,2, Samantha M Thomas3,4, Rebecca Vernon5, Oluwadamilola M Fayanju5,3,6, Laura H Rosenberger5,3, Terry Hyslop3,4, E Shelley Hwang5,3, Rachel A Greenup5,3. 1. Department of Surgery, Duke University Medical Center, 1353, Durham, NC, 27710, USA. Jennifer.Plichta@duke.edu. 2. Duke Cancer Institute, Durham, NC, USA. Jennifer.Plichta@duke.edu. 3. Duke Cancer Institute, Durham, NC, USA. 4. Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, USA. 5. Department of Surgery, Duke University Medical Center, 1353, Durham, NC, 27710, USA. 6. Department of Surgery, Durham VA Medical Center, Durham, NC, USA.
Abstract
BACKGROUND: Given presumed differences in disease severity between young (≤ 45 years) and elderly (≥ 75 years) women with breast cancer, we sought to compare tumor histopathology, stage at presentation, patterns of care, and survival at the extremes of age. METHODS: Adults with stages 0-IV breast cancer in the National Cancer Database (2004-2015) were categorized by age (18-45 years, 46-74 years, ≥ 75 years) and compared. Kaplan-Meier curves were used to visualize unadjusted overall survival (OS). A Cox proportional-hazards model was used to estimate the effect of age group, including adjustment for tumor subtype [hormone receptor [HR]+/HER2-, HER2+, triple-negative (TN)]. RESULTS: Of the 1,201,252 patients identified, 13% were ≤ 45 years and 17.5% were ≥ 75 years. Women ≤ 45 years were more likely to have higher pT/N stages and grade 3 disease compared to older patients; however, rates of de novo cM1 disease were comparable (3.7% vs 3.5%). HER2+ and TN tumors were more common in those ≤ 45 years (HER2+ : 18.6% vs 9.2%; TN: 14.9% vs 8.2%), while HR+/HER2- tumors were more likely in women ≥ 75 years (69.3% vs 51.3%) (all p < 0.001). Younger patients were more likely to undergo mastectomy vs lumpectomy (56% vs 34%), and receive chemotherapy (65.8% vs 10.2%) and radiation (56.2% vs 39.5%). After adjustment, OS was worse in older patients (older HR 2.94, CI 2.86-3.03). CONCLUSIONS: High-risk tumor subtypes and comprehensive multimodal treatment remain significantly more common among younger women (≤ 45 years) with breast cancer, yet, elderly women are similarly diagnosed with incurable de novo metastatic disease. Tailored screening and treatment strategies are critical to prevent age-related disparities in breast cancer care.
BACKGROUND: Given presumed differences in disease severity between young (≤ 45 years) and elderly (≥ 75 years) women with breast cancer, we sought to compare tumor histopathology, stage at presentation, patterns of care, and survival at the extremes of age. METHODS: Adults with stages 0-IV breast cancer in the National Cancer Database (2004-2015) were categorized by age (18-45 years, 46-74 years, ≥ 75 years) and compared. Kaplan-Meier curves were used to visualize unadjusted overall survival (OS). A Cox proportional-hazards model was used to estimate the effect of age group, including adjustment for tumor subtype [hormone receptor [HR]+/HER2-, HER2+, triple-negative (TN)]. RESULTS: Of the 1,201,252 patients identified, 13% were ≤ 45 years and 17.5% were ≥ 75 years. Women ≤ 45 years were more likely to have higher pT/N stages and grade 3 disease compared to older patients; however, rates of de novo cM1 disease were comparable (3.7% vs 3.5%). HER2+ and TN tumors were more common in those ≤ 45 years (HER2+ : 18.6% vs 9.2%; TN: 14.9% vs 8.2%), while HR+/HER2- tumors were more likely in women ≥ 75 years (69.3% vs 51.3%) (all p < 0.001). Younger patients were more likely to undergo mastectomy vs lumpectomy (56% vs 34%), and receive chemotherapy (65.8% vs 10.2%) and radiation (56.2% vs 39.5%). After adjustment, OS was worse in older patients (older HR 2.94, CI 2.86-3.03). CONCLUSIONS: High-risk tumor subtypes and comprehensive multimodal treatment remain significantly more common among younger women (≤ 45 years) with breast cancer, yet, elderly women are similarly diagnosed with incurable de novo metastatic disease. Tailored screening and treatment strategies are critical to prevent age-related disparities in breast cancer care.
Entities:
Keywords:
Age extremes; Breast cancer; Elderly; Young women
Authors: Jennifer K Plichta; Upahvan Rai; Rong Tang; Suzanne B Coopey; Julliette M Buckley; Michele A Gadd; Michelle C Specht; Kevin S Hughes; Alphonse G Taghian; Barbara L Smith Journal: Ann Surg Oncol Date: 2016-07-12 Impact factor: 5.344
Authors: L C Collins; J D Marotti; S Gelber; K Cole; K Ruddy; S Kereakoglow; E F Brachtel; L Schapira; S E Come; E P Winer; A H Partridge Journal: Breast Cancer Res Treat Date: 2011-11-13 Impact factor: 4.872
Authors: Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell Journal: J Clin Oncol Date: 2008-07-10 Impact factor: 44.544
Authors: Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood Journal: J Clin Oncol Date: 2013-05-20 Impact factor: 44.544
Authors: Nina Tamirisa; Samantha M Thomas; Oluwadamilola M Fayanju; Rachel A Greenup; Laura H Rosenberger; Terry Hyslop; E Shelley Hwang; Jennifer K Plichta Journal: Ann Surg Oncol Date: 2018-07-02 Impact factor: 5.344
Authors: Austin D Williams; Chau T Dang; Varadan Sevilimedu; Monica Morrow; Andrea V Barrio Journal: Ann Surg Oncol Date: 2022-07-24 Impact factor: 4.339
Authors: Raphael J Louie; Charles E Gaber; Paula D Strassle; Kristalyn K Gallagher; Stephanie M Downs-Canner; David W Ollila Journal: Ann Surg Oncol Date: 2020-03-25 Impact factor: 5.344
Authors: Chongshan Gu; Lize Wang; Yingjian He; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Tie Fan; Mi Li; Zhaoqing Fan Journal: Cancer Control Date: 2022 Jan-Dec Impact factor: 2.339
Authors: Jacquelyn Dillon; Samantha M Thomas; Laura H Rosenberger; Gayle DiLalla; Oluwadamilola M Fayanju; Carolyn S Menendez; E Shelley Hwang; Jennifer K Plichta Journal: Ann Surg Oncol Date: 2021-07-26 Impact factor: 4.339